FDW
BMY icon

Fourth Dimension Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Fourth Dimension Wealth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.2K Sell
250
-34
-12% -$1.98K 0.01% 365
2025
Q4 		$15.3K Buy
284
+34
+14% +$1.64K 0.01% 365
2025
Q3 		$11.3K Sell
250
-196
-44% -$9.15K ﹤0.01% 406
2025
Q2 		$20.6K Sell
446
-200
-31% -$9.82K 0.01% 316
2025
Q1 		$39.4K Sell
646
-200
-24% -$11.7K 0.02% 244
2024
Q4 		$47.9K Buy
+846
New +$47.3K 0.03% 227

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fourth Dimension Wealth's BMY Position: Q1 2026 in Review

Fourth Dimension Wealth reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q1 2026, selling an estimated $1.98K and leaving 250 shares worth $15.2K. The position accounts for 0.01% of the portfolio, ranked #365.

Fourth Dimension Wealth first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $47.9K in Q4 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Fourth Dimension Wealth held 250 shares of Bristol-Myers Squibb worth $15.2K as of Q1 2026.
  • Fourth Dimension Wealth sold 34 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.98K.
  • Bristol-Myers Squibb made up 0.01% of Fourth Dimension Wealth's portfolio in Q1 2026, its #365 holding.
  • Fourth Dimension Wealth first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Fourth Dimension Wealth's Bristol-Myers Squibb position peaked at $47.9K in Q4 2024.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Fourth Dimension Wealth's 13F filing for Q1 2026, filed 11 May 2026.